Target intelligence / Profile preview

Cell membranes and lipid signaling pathways

Molecular classification
G protein-coupled receptor, Enzyme, Lipid-binding protein, Transporter
01

Overview

Cell membranes and lipid signaling pathways represent a broad biological system rather than a single molecular target. The cell membrane serves as a dynamic platform where bioactive lipids, such as phosphoinositides, sphingolipids, and eicosanoids, are generated to act as secondary messengers in response to extracellular stimuli (Source: Nature Reviews Molecular Cell Biology). These pathways are essential for regulating fundamental cellular processes, including growth, differentiation, and programmed cell death (Source: StatPearls). Dysregulation of lipid signaling is heavily implicated in human diseases; for instance, the PI3K/Akt/mTOR pathway is one of the most frequently mutated pathways in human cancers (Source: PubMed). Additionally, lipid mediators like prostaglandins and leukotrienes are central to the inflammatory response and are the targets of widely used nonsteroidal anti-inflammatory drugs (Source: NIH). Therapeutic strategies often involve small molecule inhibitors of lipid kinases or agonists/antagonists of lipid-sensing G protein-coupled receptors (Source: Pharmacological Reviews). However, because these lipids are integral to normal physiological functions across multiple organ systems, drugs targeting these pathways often face challenges related to off-target effects and systemic toxicity.

Other names
Lipid signalingMembrane signalingBioactive lipid pathwaysPhospholipid signaling
02

Mechanism of action

Drugs targeting these pathways typically act by inhibiting lipid-modifying enzymes (e.g., PI3K, COX, or Sphingosine kinase) or by modulating G protein-coupled receptors that sense bioactive lipids (e.g., S1P receptors), thereby altering downstream intracellular signaling cascades.

03

Biological functions

Signal transductionCell proliferationApoptosisInflammationMembrane trafficking
04

Disease associations

CancerInflammationNeurodegenerative diseaseCardiovascular diseaseMetabolic disorder
05

Safety considerations

Systemic toxicity due to ubiquitous signalingImmunosuppressionGastrointestinal ulcerationHepatotoxicityCardiovascular risks
06

Interacting drugs

Fingolimod

5 more in the full profile.

07

Biomarkers

Sphingosine-1-phosphate (S1P) levelsPhosphatidylinositol (3,4,5)-trisphosphate (PIP3) expressionProstaglandin E2 (PGE2) levelsC-reactive protein (CRP)

Beyond the preview

Go deeper on Cell membranes and lipid signaling pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell membranes and lipid signaling pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call